Yifan Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 87.75 M

Yifan Pharmaceutical Co., Ltd. Operating Cash Flow is USD 87.75 M for the year ending December 31, 2024, a 78.73% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Yifan Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 49.10 M, a -28.23% change year over year.
  • Yifan Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 68.41 M, a 44.29% change year over year.
  • Yifan Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 47.41 M, a -72.08% change year over year.
  • Yifan Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 169.82 M, a 26.18% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities